Myriad Genetics
MYGN
320 Wakara Way
Salt Lake City
UT
84108
801 584 3600
Myriad Genetics is a leading biopharmaceutical company focused on the development of novel healthcare products. The Company markets molecular diagnostic tests to determine the risk of breast cancer, ovarian cancer, colon cancer, endometrial cancer and melanoma skin cancer in individuals with a family history of cancer.

Recent Interviews

Deal Flow

Fundings

Closing Date Round Amount
12/01/2000 Unattributed $94,000,000

Mergers & Acquisitions

Public Offerings

Closing Date Shares Amount
11/01/2005 8,050,000 $148,925,000
06/01/2004 3,400,000 $50,200,000
11/01/2002 3,000,000 $57,300,000

Company Video

Company Snapshot

Yes
Biotechnology | Therapeutics
1991
Active
Public
$326,530,000
$94,000,000
Link
Link
500
869

Key People

Similar Companies

Pfizer Inc
New York, NY
Merck & Co., Inc.
Whitehouse Station, NJ
MedImmune , Inc.
Gaithersburg, MD
Chiron Corporation
Emeryville, CA
Amgen Inc.
Thousand Oaks, CA

Legal Disclaimer